- Home
- WTI vs CERS Comparison
WTI vs CERS Comparison
Compare WTI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- CERS
- Stock Information
- Founded
- WTI 1983
- CERS 1991
- Country
- WTI United States
- CERS United States
- Employees
- WTI N/A
- CERS N/A
- Industry
- WTI Oil & Gas Production
- CERS EDP Services
- Sector
- WTI Energy
- CERS Technology
- Exchange
- WTI Nasdaq
- CERS Nasdaq
- Market Cap
- WTI 310.9M
- CERS 324.3M
- IPO Year
- WTI 2005
- CERS 1997
- Fundamental
- Price
- WTI $2.01
- CERS $1.72
- Analyst Decision
- WTI Strong Buy
- CERS Buy
- Analyst Count
- WTI 1
- CERS 3
- Target Price
- WTI $7.80
- CERS $3.17
- AVG Volume (30 Days)
- WTI 1.7M
- CERS 2.0M
- Earning Date
- WTI 11-07-2024
- CERS 10-30-2024
- Dividend Yield
- WTI 2.00%
- CERS N/A
- EPS Growth
- WTI N/A
- CERS N/A
- EPS
- WTI N/A
- CERS N/A
- Revenue
- WTI $537,256,000.00
- CERS $176,229,000.00
- Revenue This Year
- WTI $1.74
- CERS $26.47
- Revenue Next Year
- WTI $10.96
- CERS $11.48
- P/E Ratio
- WTI N/A
- CERS N/A
- Revenue Growth
- WTI N/A
- CERS 14.71
- 52 Week Low
- WTI $1.92
- CERS $1.38
- 52 Week High
- WTI $3.75
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- WTI 41.66
- CERS 47.71
- Support Level
- WTI $2.08
- CERS $1.59
- Resistance Level
- WTI $2.49
- CERS $2.03
- Average True Range (ATR)
- WTI 0.12
- CERS 0.14
- MACD
- WTI -0.02
- CERS 0.02
- Stochastic Oscillator
- WTI 1.02
- CERS 39.22
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.